Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 / 生化试剂 / 去垢剂 / 非离子型表面活性剂 / Tween 80/吐温80

Tween 80/吐温80 {[allProObj[0].p_purity_real_show]}

货号：A656812 同义名： 聚氧乙烯山梨糖醇酐单油酸酯 / Polysorbate 80

Tween 80 is an excipient that is used to stabilize aqueous formulations of medications for parenteral administration. It is one of the components in MF59 and AS03 adjuvant. It is a surfactant which can also reduce bacterial attachment and inhibit biofilm formation.

Tween 80/吐温80 化学结构 CAS号：9005-65-6
Tween 80/吐温80 化学结构
CAS号：9005-65-6
Tween 80/吐温80 3D分子结构
CAS号：9005-65-6
Tween 80/吐温80 化学结构 CAS号：9005-65-6
Tween 80/吐温80 3D分子结构 CAS号：9005-65-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Tween 80/吐温80 纯度/质量文件 产品仅供科研

货号：A656812 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

更多 >

Tween 80/吐温80 生物活性

描述 Tween 80 is a surfactant which can also reduce bacterial attachment and inhibit biofilm formation.

Tween 80/吐温80 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT03073525 Advanced Gynecological Cancers... 展开 >> Ovarian Cancer Cervical Cancer Uterine Cancer 收起 << Phase 2 Recruiting April 1, 2019 United States, Alabama ... 展开 >> University of South Alabama Mitchell Cancer Institute Recruiting Mobile, Alabama, United States, 36604 Contact: Rodney Rocconi, MD    251-665-8000    rocconi@health.southalabama.edu    Principal Investigator: Rodney Rocconi, MD          United States, Georgia Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Lisa Hatch, RN    706-721-4805    lhatch@augusta.edu    Principal Investigator: Sharad A Ghamande, MD          United States, Michigan Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Nicole Leon, RN    313-916-6781    sleon9@hfhs.org    Principal Investigator: Adnan Munkarah, MD          United States, Montana Billings Clinic Recruiting Billings, Montana, United States, 59101 Contact: Kathy Wilkinson, RN BSN OCN    406-435-7415    kwilkinson@billingsclinic.org    Principal Investigator: Erin Stevens, MD          United States, New Hampshire Dartmouth-Hitchcock Medical Center/ Norris Cotton Cancer Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Kathy Phipps, CCRP    603-653-3537    kathy.phipps@hitchcock.org    Principal Investigator: Leslie DeMars, MD          United States, South Carolina GHS Cancer Institute Recruiting Greenville, South Carolina, United States, 29605 Contact: Gina Norris    864-241-6251    gnorris@ghs.org    Principal Investigator: Jeffrey Elder, MD 收起 <<
NCT01635621 Crohn's Disease Phase 2 Withdrawn(Study was withdrawn ... 展开 >>due to delay in timelines. There were no safety concerns regarding the study or the compound in the decision to withdraw the trial.) 收起 << August 2013 -
NCT01266850 Rotavirus Infection Phase 4 Completed - United States, California ... 展开 >> Kaiser Permanente Vaccine Study Center Oakland, California, United States, 94612-3610 Children's Hospital & Research Center Oakland - Primary Care Clinic Oakland, California, United States, 94618-1033 United States, Georgia Emory Children's Center - Pediatric Infectious Diseases Atlanta, Georgia, United States, 30322-1014 United States, Iowa University of Iowa - Vaccine Research & Education Unit Iowa City, Iowa, United States, 52242-2600 United States, Maryland University of Maryland School of Medicine - Center for Vaccine Development - Baltimore Baltimore, Maryland, United States, 21201-1509 United States, Missouri Children's Mercy Hospital and Clinics - Infectious Diseases Kansas City, Missouri, United States, 64108-4619 United States, North Carolina Duke Translational Medicine Institute - Clinical Vaccine Unit Durham, North Carolina, United States, 27704-2120 United States, Pennsylvania Primary Physicians Research Inc. - Pittsburgh Pittsburgh, Pennsylvania, United States, 15241-3100 United States, Tennessee Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center Nashville, Tennessee, United States, 37232-2573 United States, Texas The University of Texas Medical Branch - Sealy Center for Vaccine Development (SCVD) Galveston, Texas, United States, 77555-1121 Baylor College of Medicine - Molecular Virology and Microbiology Houston, Texas, United States, 77030-3411 United States, Washington Group Health Research Institute - Seattle Seattle, Washington, United States, 98101-1466 Seattle Children's Hospital - Infectious Diseases Seattle, Washington, United States, 98105-3901 收起 <<

Tween 80/吐温80 技术信息

CAS号9005-65-6
SMILES Code NONE
MDL No. MFCD00082107
别名 聚氧乙烯山梨糖醇酐单油酸酯 ;Polysorbate 80
运输蓝冰
InChI Key HDTIFOGXOGLRCB-UHFFFAOYSA-N
Pubchem ID 443315
存储条件

In solvent -20°C:3-6个月-80°C:12个月
溶解方案 请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液，再依次添加助溶剂：
——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议现用现配，当天使用； 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶
方案一
方案二

Tags: Tween 80 | Polysorbate 80 | 聚氧乙烯山梨糖醇酐单油酸酯 | Nonionic Surfactant | AmBeed-信号通路专用抑制剂 | Tween 80/吐温80 纯度/质量文件 | Tween 80/吐温80 生物活性 | Tween 80/吐温80 临床数据 | Tween 80/吐温80 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z